EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives

Mar Teixidó Mulet, Joel Veas Rodriguez, Eduardo Terán, Miquel Piñol, Felip Vilardell, Mar Iglesias, Cinta Hierro, Mariona Calvo, Xavier Matias-Guiu, Antonieta Salud, Josep Tabernero, Robert Montal

Cancer Treatment Reviews · 2026-04 · 145 · 103124

DOI: 10.1016/j.ctrv.2026.103124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-04. Verfasst von Mar Teixidó Mulet und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Biomarkers Research Group, Hospital Universitari Arnau de Vilanova - IRBLleida, Lleida, Spain. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorImmunotherapyImmune Checkpoint InhibitorsHumansTumor Microenvironment

Stichwörter der Autor:innen

Gastric cancerImmunotherapyPredictive biomarkersTumour microenvironment

Substanzen

Biomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Biomarkers Research Group, Hospital Universitari Arnau de Vilanova - IRBLleida, Lleida, Spain.
  • Department of Medical Oncology, Cancer Biomarkers Research Group, Hospital Universitari Arnau de Vilanova - IRBLleida, Lleida, Spain; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.
  • Department of Medical Oncology, Vall d'Hebron Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), IIS IR-HUVH CIBERONC, Barcelona, Spain.
  • Department of Pathology, Oncological Pathology Group, Hospital Universitari Arnau de Vilanova - IRBLleida, Lleida, Spain.
  • Department of Pathology, Hospital del Mar, University Pompeu Fabra, Hospital del Mar Research Institute, CIBERONC, Barcelona, Spain.
  • Department of Medical Oncology, Catalan Institute of Oncology (ICO)-Badalona, Badalona-Applied Research Group in Oncology (B-ARGO)/CARE-IGTP (Germans Trias i Pujol Institute), Universitat Autònoma de Barcelona (UAB), Ba…

Förderung

  • European Commission
  • Carlos III Health Institute

Zitieren

APA

Teixidó Mulet, M., Veas Rodriguez, J., Terán, E., Piñol, M., Vilardell, F., Iglesias, M., Hierro, C., Calvo, M., Matias-Guiu, X., Salud, A., Tabernero, J., & Montal, R. (2026). Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives. Cancer Treatment Reviews, 145, 103124. https://doi.org/10.1016/j.ctrv.2026.103124

Vancouver

Teixidó Mulet M, Veas Rodriguez J, Terán E, Piñol M, Vilardell F, Iglesias M, et al. Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives. Cancer Treatment Reviews. 2026;145:103124. doi:10.1016/j.ctrv.2026.103124

BibTeX
@article{TeixidMulet2026,
  author = {Teixidó Mulet, Mar and Veas Rodriguez, Joel and Terán, Eduardo and Piñol, Miquel and Vilardell, Felip and Iglesias, Mar and Hierro, Cinta and Calvo, Mariona and Matias-Guiu, Xavier and Salud, Antonieta and Tabernero, Josep and Montal, Robert},
  title = {Biomarker-guided immunotherapy in gastric cancer: current insights and future perspectives},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {145},
  pages = {103124},
  doi = {10.1016/j.ctrv.2026.103124}
}
Kostenlos starten →